Effectiveness of Synbiotic and Vitamin D in Atopic Dermatitis

Study of the effectiveness of Synbiotic and Vitamin D on the Severity of Atopic Dermatitis in 1 to 24 Months Old Children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180626040248N1

Enrollment

Registered

2018-09-22

Start date

1988-07-11

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis. Atopic dermatitisExcl.:circumscribed neurodermatitis (L28.0)L20.0Besnier prurigoL20.8Other atopic dermatitisEczema:flexural NECinfantile (acute)(chronic)intrinsic (allergic)Neurodermatitis:atopicdiffuseL20.9Atopic dermatitis, unspecifiedL21

Interventions

Intervention 1: Intervention group1: In this group, patients receive 5 drops of pedilact daily for two months in addition to routine treatments . pedilact is a synbiotic ( prebiotic + probiotic). Int

Eligibility

Sex/Gender

All

Age

1 Months to 24 Months

Inclusion criteria

Inclusion criteria: Being 1-24 month of age Absence of any other chronic disease Having used no immunosuppressive medicines, corticosteroids and antibiotics for one week prior of the study Mother's willingness

Exclusion criteria

Exclusion criteria: Infectious disease Receive immunosuppressive medicines, corticosteroids and antibiotics Mother's unwillingness

Design outcomes

Primary

Measure	Time frame
Score of Atopic Dermatitis according to SCORAD. Timepoint: Beginning and end of the study (week 8). Method of measurement: SCORAD (scoring of Atopic Dermatitis).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Shamabadi

Sabzevar University of Medical Sciences

fatemeh.shamabadi@medsab.ac.ir+98 51 4441 0325

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026